Latin America Exosomes Market Size & Outlook, 2023-2030

The exosomes market in Latin America is expected to reach a projected revenue of US$ 21.3 million by 2030. A compound annual growth rate of 22.9% is expected of Latin America exosomes market from 2024 to 2030.
Revenue, 2023 (US$M)
$5.0
Forecast, 2030 (US$M)
$21.3
CAGR, 2024 - 2030
23%
Report Coverage
Latin America

Latin America exosomes market highlights

  • The Latin America exosomes market generated a revenue of USD 5.1 million in 2023.
  • The market is expected to grow at a CAGR of 27.4% from 2024 to 2030.
  • In terms of segment, kits & reagents was the largest revenue generating product in 2023.
  • Kits & Reagents is the most lucrative product segment registering the fastest growth during the forecast period.
  • Country-wise, Brazil is expected to register the highest CAGR from 2024 to 2030.


Latin America data book summary

Market revenue in 2023USD 5.1 million
Market revenue in 2030USD 27.5 million
Growth rate27.4% (CAGR from 2023 to 2030)
Largest segmentKits & reagents
Fastest growing segmentKits & Reagents
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationKits & Reagents, Instruments, Services
Key market players worldwideDanaher Corp, Hologic Inc, FUJIFILM Holdings Corp, Lonza Group Ltd, Miltenyi Biotec, Bio-Techne Corp, Qiagen NV, Thermo Fisher Scientific Inc, Abcam PLC, RoosterBio


Other key industry trends

  • In terms of revenue, Latin America region accounted for 3.6% of the global exosomes market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • North America is the fastest growing regional market and is projected to reach USD 615.5 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Exosomes Market Companies

Name Profile # Employees HQ Website

Latin America exosomes market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to exosomes market will help companies and investors design strategic landscapes.


Kits & reagents was the largest segment with a revenue share of 45.1% in 2023. Horizon Databook has segmented the Latin America exosomes market based on kits & reagents, instruments, services covering the revenue growth of each sub-segment from 2018 to 2030.


Development in Latin America is restricted due to the economic crisis and political turmoil. Although there is high incidence of several infectious diseases such as Chagas in the region, government spending on advanced medical care is very less. However, the region has made considerable progress over past few decades.

Economic progress in countries such as Brazil, Argentina, Chile, and Mexico has contributed to the overall economic growth in the region. Brazil has highest revenue share due to its rapid industrial and research development.

Moreover, increase in the number of Next-Generation Sequencing (NGS) installation bases in this region is expected to impact market growth in the coming years as NGS is one of the key technologies associated in the downstream analysis of exosomes.

Reasons to subscribe to Latin America exosomes market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Latin America exosomes market databook

  • Our clientele includes a mix of exosomes market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America exosomes market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America exosomes market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Latin America exosomes market size, by country, 2018-2030 (US$M)

Latin America Exosomes Market Outlook Share, 2023 & 2030 (US$M)

Latin America exosomes market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more